Harold W.  Andrews, Jr. net worth and biography

Harold Andrews, Jr. Biography and Net Worth

Harold Andrews, Jr. served as Sabra’s Treasurer and Secretary from May 2010 to November 2010 and has served as Sabra’s Executive Vice President, Chief Financial Officer and Secretary since November 2010. From 1997 to 2017, Mr. Andrews was a member and member of the Management Committee of Journey Health Properties, LLC and Journey Lane 5, LLC, two real estate holding entities he organized to own and lease specialized healthcare facilities and a commercial office building. From 1997 to May 2008, Mr. Andrews also was a member and member of the Management Committee and Chief Financial Officer of CareMeridian. Previously, from 1996 to 1997, Mr. Andrews served as the Vice President of Finance for Regency Health Services, Inc., a provider of post-acute care services. Prior to that time, he spent 10 years in public accounting at Arthur Andersen LLP, including serving as Senior Manager for publicly traded healthcare and real estate companies. Mr. Andrews is a Certified Public Accountant and a member of the AICPA and Financial Executives International. He also serves on the Board of Directors of Links Players International, a nonprofit organization.

How do I contact Harold W. Andrews, Jr.?

The corporate mailing address for Mr. Andrews, Jr. and other Sabra Health Care REIT executives is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. Sabra Health Care REIT can also be reached via phone at (888) 393-8248 and via email at [email protected]. Learn More on Harold W. Andrews, Jr.'s contact information.

Has Harold W. Andrews, Jr. been buying or selling shares of Sabra Health Care REIT?

Harold W. Andrews, Jr. has not been actively trading shares of Sabra Health Care REIT in the last ninety days. Learn More on Harold W. Andrews, Jr.'s trading history.

Who are Sabra Health Care REIT's active insiders?

Sabra Health Care REIT's insider roster includes Harold Andrews, Jr. (CFO), Michael Costa (CFO), Catherine Cusack (Director), and Michael Foster (Director). Learn More on Sabra Health Care REIT's active insiders.

Are insiders buying or selling shares of Sabra Health Care REIT?

During the last twelve months, Sabra Health Care REIT insiders bought shares 1 times. They purchased a total of 7,000 shares worth more than $101,010.00. The most recent insider tranaction occured on May, 22nd when Director Catherine Cusack bought 7,000 shares worth more than $101,010.00. Insiders at Sabra Health Care REIT own 1.1% of the company. Learn More about insider trades at Sabra Health Care REIT.

Information on this page was last updated on 5/22/2024.

Harold W. Andrews, Jr. Insider Trading History at Sabra Health Care REIT

See Full Table

Harold W. Andrews, Jr. Buying and Selling Activity at Sabra Health Care REIT

This chart shows Harold W Jr. Andrews's buying and selling at Sabra Health Care REIT by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sabra Health Care REIT Company Overview

Sabra Health Care REIT logo
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.
Read More

Today's Range

Now: $16.96
Low: $16.53
High: $17.09

50 Day Range

MA: $18.46
Low: $16.73
High: $19.67

2 Week Range

Now: $16.96
Low: $12.83
High: $20.03

Volume

5,428,297 shs

Average Volume

2,064,589 shs

Market Capitalization

$4.01 billion

P/E Ratio

41.37

Dividend Yield

7.10%

Beta

1.24